G1 Therapeutics Inc (GTHX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,967 | -147,559 | -148,352 | -99,254 | -122,447 |
| Depreciation Amortization | 1,986 | 2,763 | 1,582 | 1,197 | 356 |
| Accounts receivable | -1,593 | -5,406 | -5,451 | -237 | N/A |
| Other Working Capital | -5,203 | -5,307 | -8,838 | -4,076 | 6,071 |
| Other Operating Activity | 14,440 | 26,889 | 28,951 | 18,628 | 16,449 |
| Operating Cash Flow | $-38,337 | $-128,620 | $-132,108 | $-83,742 | $-99,571 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,810 | -50,023 | 0 | N/A | N/A |
| PPE Investments | N/A | -506 | N/A | 152 | -2,716 |
| Investing Cash Flow | $2,810 | $-50,529 | $0 | $152 | $-2,716 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 0 | 55,000 | 20,000 | N/A |
| Debt Repayment | -26,688 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 57 | 52,538 | 92,274 | 2,308 | 2,705 |
| Common Stock Repurchased | -281 | -43 | -51 | 0 | N/A |
| Other Financing Activity | 0 | 0 | -1,360 | -620 | 0 |
| Financing Cash Flow | $-26,912 | $52,495 | $145,863 | $21,688 | $2,705 |
| Beginning Cash Position | 94,907 | 221,561 | 207,806 | 269,708 | 369,290 |
| End Cash Position | 32,468 | 94,907 | 221,561 | 207,806 | 269,708 |
| Net Cash Flow | $-62,439 | $-126,654 | $13,755 | $-61,902 | $-99,582 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,337 | -128,620 | -132,108 | -83,742 | -99,571 |
| Capital Expenditure | 0 | -506 | 0 | 0 | -2,716 |
| Free Cash Flow | -38,337 | -129,126 | -132,108 | -83,742 | -102,287 |